Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Renub Research | PRODUCT CODE: 1594284

Cover Image

PUBLISHER: Renub Research | PRODUCT CODE: 1594284

Adhesion Barriers Market Global Forecast Report by Product, Formulation, Application, Countries and Company Analysis 2025-2033

PUBLISHED:
PAGES: 115 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2990
PDF (5 User License + Excel)
USD 3490
PDF (Corporate License)
USD 3990

Add to Cart

Adhesion Barriers Market Size

The adhesive barriers market is expected to grow from US$1,005.6 million in 2024 to US$1,981.8 million by 2033, with a CAGR of 7.83% during the forecast period 2025-2033. Growth strength is added through increased demand for film-based medical implants in urological, reconstructive, and cardiovascular procedures.

Global Adhesion Barriers Industry Overview

Adhesion barriers are medical devices or products designed to limit or prevent abnormal adhesions or scar tissue after surgery. These would be biocompatible materials, many artificial polymers or natural substances that may become a protective interpositional layer between tissues, preventing them from sticking together as they heal. Most often, adhesion barriers are employed in surgical procedures in which tissues are likely to come into contact, like urological, gynecological, cardiovascular, and abdominal surgeries.

The most important use of adhesion barriers is avoiding postoperative complications in the form of adhesions, which favor pain, infertility, bowel obstruction, and other severe health states. In short, adhesion barriers minimize the risks of such complications that further enhance recovery times and long-term outcomes in patients. They also minimize additional surgeries that are needed to treat complications arising from adhesions, and therefore, play an important role in improving the safety and efficacy of several surgical interventions.

Old-aged people are the most significant social transformations now. According to the United Nations, the number of people who were over 60 years old in 2017 reached about 962 million all over the world. The population is estimated to double by 2050 and triple by 2100. Population aged 60 or older grows faster than any younger age group, contributing to the growth of the global market.

Growth Drivers for the Adhesion Barriers Market

Increasing Surgical Procedures

Increasing number of surgeries performed, mainly, in abdominal, gynecological, urological, and cardiovascular surgeries, is a major driver for the adhesion barriers market. Increased procedures on patients with an increase in health conditions such as obesity, cancer, and cardiovascular diseases increases the likelihood of post-surgical adhesions. It prevents a number of complications that may manifest themselves as pain, infertility, or bowel obstruction and lead to prolonged hospital stays or additional surgery. Increased surgical volumes will create a need for effective solutions such as adhesion barriers. According to ISAPS, the global total of surgical and nonsurgical procedures had reached 34.9 million by 2023, an increase of 3.4% from the previous year.

Advancements in Medical Technology

Advances in adhesion barrier materials are major drivers for growth in the market. Improvements in results and enhanced safety profiles have been seen with newer biocompatible and biodegradable films such as synthetic films. These technologies provide superior tissue protection, faster recovery, and a lower likelihood of complications. Improvements in the delivery system allow adhesion barriers to be more convenient to apply since they may be delivered as sprayable products or in ready-to-use devices, which enhances their adoption into the clinic. The technology is improving, and adhesion barriers will continue to be integral to postoperative care if they continue to progress with better outcomes and recovery for the patient.

Growing Awareness of Post-Surgical Complications

As the awareness with regard to the ill effects of adhesions resulting from surgeries grows, so does the growing level of recognition by healthcare providers and patients alike to the importance of adhesion barriers. Practising physicians are now taking more aggressive steps in preventing adhesion-related complications, especially for patients undergoing high-risk surgeries. Conversely, with patients being now more informed about the kinds of late-stage health problems they may face with adhesions, the demand for prevention solutions increases. This increasing awareness in about adhesion barriers and other healthcare efforts to enhance the outcome of patients through educational campaigns and clinical studies will further fuel the growing demand for adhesion barriers.

Canada Adhesion Barriers Market

Canada Adhesion Barriers market is also on the growth trajectory due to the surgical procedures especially abdominal, gynecological, and urological surgeries that might prove problematic after surgery owing to adhesions. Along with the efforts being paid to patient safety and avoiding possible health hazard issues, the need for effective adhesion prevention products is also on the rise. Advances in biocompatible and biodegradable technologies drive innovation to increasingly more efficient and safer adhesion barriers. In addition, greater sensitivity within healthcare professionals and patients regarding dangers associated with adhesions as well as the benefits of adhesion barriers expand the demand for the product in Canada.

France Adhesion Barriers Market

The France Adhesion Barriers market is growing at a particular rate, due to the high number of surgeries being performed, especially abdominal, gynecological, and urological. The concern about the complications arising post the surgery by adhesions is slowly on the rise. This, in turn, increases the demand for solutions that prevent the formation of adhesions. Innovations in adhesion barrier technologies have increased the overall demand, including the biocompatible and biodegradable materials designed for better safety efficacy. With the increasing adoption of adhesion barriers by healthcare providers for enhancing better patient outcome, shorter recovery times, and fewer chance reoperations, FzioMed, Inc. will participate in ESGE 33rd annual congress in Marseille, France, between 27-30th October 2024, and its Oxiplex/IU(R) and Oxiplex/AP(R) adhesion barrier gels that prevent surgical procedure-induced adhesions.

India Adhesion Barriers Market

The India Adhesion Barriers market has been growing steadily with the rise of surgical procedures, especially in abdominal, gynecological, and urological surgeries. Such conditions often result in post-surgical complications such as infertility, chronic pain, and even bowel obstruction. With such risks increased with each surgery case, demand for adhesion barriers is growing with healthcare providers wanting to minimize these risks and help patients recover better. Advances in biocompatible and biodegradable materials and growing awareness of the benefits of adhesion prevention also propel growth in the market. With rapid development in health care infrastructure and patient awareness in India, this trend too contributes to growth.

UAE Adhesion Barriers Market

Adhesion barriers market in the UAE is finding growth spurts on account of increasing surgical procedures in general, and specifically, abdominal, gynecological, and cardiovascular surgeries. In the meantime, the prevalence of obesity, cancer, and cardiovascular diseases is also increasing the market for adhesion prevention. Healthcare professionals are increasingly utilizing adhesion barriers to reduce post-surgical complications such as adhesions, causing pain, infertility, and bowel obstruction. Furthermore, the development of materials that are bio-compatible and biodegradable, along with enhanced awareness in patients related to the advantages of using adhesion barriers, is boosting the growth of the market in UAE, thus providing better surgical results.

Adhesion Barriers Company Analysis

The major participants in the Adhesive Barriers market include Anika Therapeutics, Inc., Baxter International, Inc., Integra LifeSciences Holdings Corporation, Johnson & Johnson, Medtronic Plc, Medical Devices Business Services, Inc., and Groupe Sanofi.

Product- Industry is divided into 2 viewpoints:

1. Synthetic

2. Natural

Formulation- Industry is divided into 3 viewpoints:

1. Film

2. Liquid

3. Gel

Application- Industry is divided into 8 viewpoints:

1. Gynecological Surgeries

2. General/Abdominal Surgeries

3. Cardiovascular Surgeries

4. Orthopedic Surgeries

5. Neurological Surgeries

6. Reconstructive Surgeries

7. Urological Surgeries

8. Others

Countries- Industry is divided into 25 viewpoints:

North America

  • United States
  • Canada

Europe

  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Belgium
  • Netherlands
  • Turkey

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Thailand
  • Malaysia
  • Indonesia
  • New Zealand

Latin America

  • Brazil
  • Mexico
  • Argentina

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • United Arab Emirates

All companies have been covered with 5 Viewpoints

1. Overview

2. Key Persons

3. Recent Development & Strategies

4. Product Portfolio

5. Financial Insights

Company Analysis

1. Anika Therapeutics, Inc.

2. Baxter International, Inc.

3. Integra LifeSciences Holdings Corporation

4. Johnson & Johnson

5. Medtronic Plc

6. Medical Devices Business Services, Inc.

7. Groupe Sanofi

Table of Contents

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Global Adhesion Barriers Market

6. Market Share Analysis

  • 6.1 Product
  • 6.2 Formulation
  • 6.3 Application
  • 6.4 Country

7. Product

  • 7.1 Synthetic
  • 7.2 Natural

8. Formulation

  • 8.1 Film
  • 8.2 Liquid
  • 8.3 Gel

9. Application

  • 9.1 Gynecological Surgeries
  • 9.2 General/Abdominal Surgeries
  • 9.3 Cardiovascular Surgeries
  • 9.4 Orthopedic Surgeries
  • 9.5 Neurological Surgeries
  • 9.6 Reconstructive Surgeries
  • 9.7 Urological Surgeries
  • 9.8 Others

10. Country

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
  • 10.2 Europe
    • 10.2.1 France
    • 10.2.2 Germany
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Belgium
    • 10.2.7 Netherlands
    • 10.2.8 Turkey
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 Australia
    • 10.3.5 South Korea
    • 10.3.6 Thailand
    • 10.3.7 Malaysia
    • 10.3.8 Indonesia
    • 10.3.9 New Zealand
  • 10.4 Latin America
    • 10.4.1 Brazil
    • 10.4.2 Mexico
    • 10.4.3 Argentina
  • 10.5 Middle East & Africa
    • 10.5.1 South Africa
    • 10.5.2 Saudi Arabia
    • 10.5.3 UAE

11. Porter's Five Analysis

  • 11.1 Bargaining Power of Buyers
  • 11.2 Bargaining Power of Suppliers
  • 11.3 Degree of Rivalry
  • 11.4 Threat of New Entrants
  • 11.5 Threat of Substitutes

12. SWOT Analysis

  • 12.1 Strength
  • 12.2 Weakness
  • 12.3 Opportunity
  • 12.4 Threat

13. Company Analysis

  • 13.1 Anika Therapeutics, Inc.
    • 13.1.1 Overview
    • 13.1.2 Key Persons
    • 13.1.3 Recent Development & Strategies
    • 13.1.4 Product Portfolio
    • 13.1.5 Financial Insights
  • 13.2 Baxter International, Inc.
    • 13.2.1 Overview
    • 13.2.2 Key Persons
    • 13.2.3 Recent Development & Strategies
    • 13.2.4 Product Portfolio
    • 13.2.5 Financial Insights
  • 13.3 Integra LifeSciences Holdings Corporation
    • 13.3.1 Overview
    • 13.3.2 Key Persons
    • 13.3.3 Recent Development & Strategies
    • 13.3.4 Product Portfolio
    • 13.3.5 Financial Insights
  • 13.4 Johnson & Johnson
    • 13.4.1 Overview
    • 13.4.2 Key Persons
    • 13.4.3 Recent Development & Strategies
    • 13.4.4 Product Portfolio
    • 13.4.5 Financial Insights
  • 13.5 Medtronic Plc
    • 13.5.1 Overview
    • 13.5.2 Key Persons
    • 13.5.3 Recent Development & Strategies
    • 13.5.4 Product Portfolio
    • 13.5.5 Financial Insights
  • 13.6 Medical Devices Business Services, Inc.
    • 13.6.1 Overview
    • 13.6.2 Key Persons
    • 13.6.3 Recent Development & Strategies
    • 13.6.4 Product Portfolio
    • 13.6.5 Financial Insights
  • 13.7 Sanofi
    • 13.7.1 Overview
    • 13.7.2 Key Persons
    • 13.7.3 Recent Development & Strategies
    • 13.7.4 Product Portfolio
    • 13.7.5 Financial
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!